Loading clinical trials...
Loading clinical trials...
A Randomized Clinical Trial of 4 Months of Rifampin vs. 9 Months of Isoniazid for Latent Tuberculosis Infection. Part 3 - Effectiveness
Conditions
Interventions
Isoniazid
Rifampin
Locations
12
Australia
Woolcock Institute of Medical Research
Sydney, New South Wales, Australia
Centre de Pneumophthysiologie
Cotonou, Benin
Universidade Gama Filho, Centro de Ciências Biológicas e da Saúde
Rio de Janeiro, Brazil
University of Alberta
Edmonton, Alberta, Canada
British Columbia Centre for Disease Control
Vancouver, British Columbia, Canada
Montreal Chest Institute
Montreal, Quebec, Canada
Start Date
August 1, 2009
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
December 19, 2017
NCT06033807
NCT05746611
NCT00804713
NCT02641106
NCT01622140
NCT02225158
Lead Sponsor
McGill University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions